HepG2 and Hep3B cells were treated with various FAs, of which PA reduced PHF2 levels (Supplementary Fig. 1a); PA also reduced PHF2 expression in other liver cancer cell lines (Supplementary Fig. 1b). This evidence concerns the gene PHF2 and liver cancer.